Immunic, Inc. (IMUX)
6.99
-0.40
(-5.41%)
USD |
NASDAQ |
Nov 20, 16:00
7.035
+0.04
(+0.64%)
Pre-Market: 20:00
Immunic Max Drawdown (5Y) : 99.70% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 99.70% |
| September 30, 2026 | 99.70% |
| August 31, 2026 | 99.70% |
| July 31, 2026 | 99.70% |
| June 30, 2026 | 99.70% |
| May 31, 2026 | 99.70% |
| April 30, 2026 | 99.70% |
| March 31, 2026 | 99.70% |
| February 28, 2026 | 99.70% |
| January 31, 2026 | 99.70% |
| December 31, 2025 | 99.70% |
| November 30, 2025 | 99.70% |
| October 31, 2025 | 99.70% |
| September 30, 2025 | 99.70% |
| August 31, 2025 | 99.70% |
| July 31, 2025 | 99.70% |
| June 30, 2025 | 99.70% |
| May 31, 2025 | 99.70% |
| April 30, 2025 | 99.70% |
| March 31, 2025 | 99.70% |
| February 28, 2025 | 99.70% |
| January 31, 2025 | 99.70% |
| December 31, 2024 | 99.70% |
| November 30, 2024 | 99.70% |
| October 31, 2024 | 99.70% |
| Date | Value |
|---|---|
| September 30, 2024 | 99.70% |
| August 31, 2024 | 99.70% |
| July 31, 2024 | 99.70% |
| June 30, 2024 | 99.70% |
| May 31, 2024 | 99.70% |
| April 30, 2024 | 99.70% |
| March 31, 2024 | 99.70% |
| February 29, 2024 | 99.70% |
| January 31, 2024 | 99.70% |
| December 31, 2023 | 99.70% |
| November 30, 2023 | 99.70% |
| October 31, 2023 | 99.70% |
| September 30, 2023 | 99.70% |
| August 31, 2023 | 99.70% |
| July 31, 2023 | 99.70% |
| June 30, 2023 | 99.70% |
| May 31, 2023 | 99.70% |
| April 30, 2023 | 99.70% |
| March 31, 2023 | 99.70% |
| February 28, 2023 | 99.70% |
| January 31, 2023 | 99.70% |
| December 31, 2022 | 99.70% |
| November 30, 2022 | 99.65% |
| October 31, 2022 | 99.64% |
| September 30, 2022 | 99.64% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 66.41% |
| Anika Therapeutics, Inc. | 83.15% |
| Savara, Inc. | 93.79% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -55.62 |
| Beta (5Y) | 1.485 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 94.86% |
| Historical Sharpe Ratio (5Y) | -0.4578 |
| Historical Sortino (5Y) | -0.8832 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.75% |